Cargando…
Patients with interferon expressing oral pathologies are susceptible to COVID-19 infection
Autores principales: | Sarode, Gargi S., Sarode, Sachin C., Gadbail, Amol R., Gondivkar, Shailesh, Kumar Sharma, Nilesh, Patil, Shankargouda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422813/ https://www.ncbi.nlm.nih.gov/pubmed/33254501 http://dx.doi.org/10.1016/j.mehy.2020.110179 |
Ejemplares similares
-
Are oral manifestations related to SARS-CoV-2 mediated hemolysis and anemia?
por: Sarode, Gargi S., et al.
Publicado: (2021) -
Clinical status determines the efficacy of salivary and nasopharyngeal samples for detection of SARS-CoV-2
por: Sarode, Gargi S., et al.
Publicado: (2020) -
Oral submucous fibrosis and COVID-19: Perspective on comorbidity
por: Sarode, Sachin C., et al.
Publicado: (2020) -
Measurement properties of oral health related patient reported outcome measures in patients with oral cancer: A systematic review using COSMIN checklist
por: Gondivkar, Shailesh M., et al.
Publicado: (2019) -
Impact of Oral Lichen Planus on Oral Health-Related Quality of Life: A Systematic Review and Meta-Analysis
por: Yuwanati, Monal, et al.
Publicado: (2021)